Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease

Simon Lalonde1, Valérie-Anne Codina-Fauteux1,2, Sébastian Méric de Bellefon1,2

  • 1Montreal Heart Institute, 5000 Belanger street, Montréal, Québec, H1T 1C8, Canada.

Genome Biology
|July 10, 2019
PubMed

Insights

Genetic variants linked to coronary artery disease (CAD) and blood pressure (BP) influence endothelial cells. This study maps these variants to regulatory elements, revealing their role in vascular disease risk.

Area of Science:

  • Genomics
  • Cardiovascular Science
  • Cell Biology

Background:

  • Genome-wide association studies (GWAS) have identified numerous loci for coronary artery disease (CAD) and blood pressure (BP), but their functional mechanisms are often unclear.
  • Many identified loci lack links to traditional risk factors or obvious candidate genes, hindering functional characterization.
  • Endothelial cells are crucial for vascular homeostasis, and their dysfunction is implicated in atherosclerosis and hypertension, suggesting a role for endothelial-specific gene regulation in vascular diseases.

Purpose of the Study:

  • To investigate the hypothesis that GWAS loci associated with vascular diseases modulate endothelial cell functions.
  • To create an integrated map of gene expression, open chromatin, and 3D interactions in human endothelial cells under resting and inflammatory conditions.
  • To identify regulatory elements in endothelial cells that harbor genetic variants associated with CAD and BP.

Main Methods:

  • Generation of an integrated map of gene expression, open chromatin regions, and 3D genome interactions in human endothelial cells.
  • Analysis of enrichment of CAD and BP single nucleotide polymorphisms (SNPs) within endothelial cell open chromatin regions.
  • Utilizing Hi-C data to link open chromatin regions containing disease-associated SNPs to gene promoters.
  • Validation of a CAD locus using CRISPR/Cas9 gene editing to assess the impact on gene expression.

Main Results:

  • Genetic variants associated with CAD and BP are significantly enriched in open chromatin regions of endothelial cells.
  • Identification of 991 regulatory element-gene promoter combinations linked to 38 CAD and 92 BP GWAS loci.
  • Successful validation of a CAD-associated regulatory element's role in modulating the expression of a novel candidate gene, AIDA.

Conclusions:

  • Genetic variants acting within the vascular endothelium play a significant role in modulating individual risk for CAD and hypertension.
  • The findings highlight the importance of endothelial cell-specific regulatory elements in the genetic architecture of vascular diseases.
  • This study provides a valuable resource for understanding the functional impact of GWAS findings in vascular biology.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.0K